BioSpecifics Technologies Corp. (BSTC) shares are trading at higher $88.69, while the current analyst price target stands at $100.00.
To add more color to this target, the company’s high over the last year is $69.73 and the low is $42.00. Over the last 52 weeks, BSTC is up 81.82% while the S&P 500 is up 14.78%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, BSTC reported a profit of $4.15 million. BioSpecifics Technologies Corp. also saw revenues increase to $3.9 million. In addition, BSTC has free cash flow of $14.76 million as of 06-2020. The company’s EBITDA came in at $10000.0 which compares well with its peers.
BSTC booked profit margins of 52.50%, its Return on Equity (ROE) is 14.60%, and its Return on Assets is 14.20%. All told, it is clear that, BSTC needs to be on your watchlist.
Find out when BSTC reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. BSTC has a short ratio of 7.29 and outstanding shares of 7.34M.
BSTC has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 28280.0 and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 2.48. BioSpecifics Technologies Corp. BSTC also noted assets of $133.78 million at the end of the last quarter. Investors should also keep an eye on sector updates as BSTC has historically followed its peers on positive news.
All told, BioSpecifics Technologies Corp. BSTC has strung together solid data and demonstrated underlying fundamentals. At its current valuation, BSTC represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
BioSpecifics Technologies Corp. BSTC is now commanding a market cap of 654.53M and a float of 5.76M. BSTC is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of BSTC stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in BSTC, either long or short, and we have not been compensated for this article.